#Japan #Tokyo #AI Healthcare #Tech Doctor #Digital Biomarkers

Tech Doctor's Major Funding Round

Tokyo-based Tech Doctor, a leader in developing digital biomarkers (dBM), has recently announced a significant funding achievement. The company has secured approximately 1.2 billion yen through a combination of third-party allocation of shares and bank financing during a Series B funding round. This brings its total funding to date to about 1.8 billion yen.

Tech Doctor's funding sources include existing investors such as JAFCO Group, Japan Venture Capital, and Mitsui Sumitomo Insurance Capital, alongside new participants including Daiwa Corporate Investment, Miraidoa (Aska Pharmaceutical), Yamaguchi Capital, Resona Capital, Ono Digital Health Investment, and Lion, showcasing a robust interest in the company's innovative approach to healthcare technology.

Founded in June 2019, Tech Doctor has dedicated itself to creating continuous indicators from daily biometric data, effectively providing objective measures of health conditions and the impact of treatments. The company has engaged in over 100 research collaborations with various companies and research institutions, focusing on a diverse range of diseases and quality of life indicators. This collaboration emphasizes their commitment to implementing these measures in real-world medical and healthcare scenarios.

Commitment to Social Implementation

Tech Doctor is focusing on the social implementation of their digital biomarkers. They aim to leverage the latest advancements in artificial intelligence to enhance research and development structures devoted to the practical application of such biomarkers. By combining data with AI, the company seeks to address personalized healthcare needs and broaden the horizons of medical possibilities for individuals.

Details of the Funding

• - Amount Raised: Approximately 1.2 billion yen
• - New Investors: Notable participants in the current funding round include:

- JAFCO SV6 Investment Limited Liability Partnership
- Japan Venture Capital NVCC9 Fund
- Mitsui Sumitomo Insurance Capital MSIVC2023V Fund
- Daiwa Corporate Investment DCI Venture Growth Support Fund
- Various others who share the vision of improved healthcare through innovative technology.

Investor Insights

Several investors expressed their confidence in Tech Doctor's vision:

• - JAFCO Group Partner Junji Fujii commented on Tech Doctor's dual capability in not just being a medical R&D startup but also performing consistently like an IT and AI startup, which adds significant value creation potential.

• - Japan Venture Capital Executive Vice President Hiroyuki Kuamura noted the increasing recognition around digital biomarkers and the company’s ambitious goals, alluding to the team's unwavering spirit and dedication.

• - Mitsui Sumitomo Insurance Capital Manager Yuichi Hosoya recognized the rapid development of digital biomarkers facilitated by wearable devices, asserting confidence in the promise of 'data improving healthcare' being within reach.

Future Aspirations

The funds raised will be allocated towards accelerating the social implementation of Tech Doctor's core technology, focusing on enhancing AI solutions for practical healthcare applications. Plans include establishing a more rigorous research framework to explore medical and healthcare applications of digital biomarkers and developing practical solutions derived from AI.

Through this endeavor, Tech Doctor aspires to utilize data and AI to ensure personalized medical solutions are available to everyone. The company envisions a future where individual health is prioritized through continuous biometric analysis, setting the stage for innovative healthcare solutions.

About Tech Doctor

Tech Doctor is poised to lead the shift towards a data-driven health improvement era, with a focus on creating insights from everyday sensing data through digital biomarkers. The company collaborates closely with enterprises in healthcare, pharmaceuticals, and food sectors to realize personalized data-driven healthcare solutions.

Company Name: Tech Doctor, Inc.
Website: Tech Doctor
Founded: June 21, 2019
Location: 4th Floor, Kyobashi Edogrand, 2-2-1 Kyobashi, Chuo-ku, Tokyo
CEO: Kazushi Minato
Business Focus: Development and operation of the digital biomarker platform 'SelfBase' and offering digital health solutions.